JXL-069 belongs to mitochondrial pyruvate carrier (MPC) inhibitors, which do not regulate hormones but promote hair growth by altering the metabolic pattern of hair follicle stem cells. JXL-069 blocks the entry of pyruvate into mitochondria, causing pyruvate to remain in the cytoplasm and be converted into lactate by lactate dehydrogenase. Lactic acid, as a metabolic signal, can awaken dormant hair follicle stem cells and allow dormant hair follicles to enter the growth phase again.
Many people with hair loss do not have their hair follicles disappear, but rather remain in a dormant period for a long time, no longer growing thick and hard terminal hair. JXL-069 activates hair follicle stem cell proliferation through this metabolic reprogramming pathway, restarts the hair growth cycle, and promotes the gradual transformation of fine hairs into thick and normal hair.
Faithful Chemical offers both of these products. We provide high-quality service, ensuring that our products are of superior quality and meet international pharmaceutical standards. You can source products from Faithful Chemical with complete confidence.
JXL-069 Description

Introduction to JXL-069
JXL-069,CAS:2260696-63-5, It is a mitochondrial pyruvate carrier (MPC) small molecule inhibitor, only for laboratory research use and cannot be directly used as a drug for humans. Its main function is to block the entry of pyruvate into mitochondria, alter the energy metabolism of cells, and enable them to produce lactate more through anaerobic pathways. This substance was originally developed for hair loss related purposes. Animal testing has shown that it can stimulate hair follicles both internally and externally, aid in hair growth, and also be used to study changes in hair follicle cycles. It is also commonly used for testing mitochondrial metabolism and stem cell metabolism, and is a commonly used tool compound in metabolic pathway research. The general supply on the market is white powder, with a purity of over 99%. Storage should be kept away from light and moisture to prevent structural deterioration. It should be noted that JXL-069 is still in the basic research stage and its safety has not been fully validated. It is not suitable for direct use as a skincare or oral product.
Molecular characteristics of JXL-069
JXL-069 is a small molecule mitochondrial pyruvate carrier inhibitor with stable molecular structure and good cell penetration ability, which can smoothly penetrate the cell membrane and exert its effects. It can specifically bind to mitochondrial pyruvate carrier protein, blocking the transport of pyruvate into mitochondria without indiscriminately interfering with many other metabolic proteins, and has outstanding target selectivity.
This molecule has moderate lipid solubility and performs well in commonly used laboratory organic solvents, making it convenient to prepare solutions for cell level testing. Its molecular binding mode belongs to reversible binding, and after removal, the pyruvate transport function has the opportunity to slowly recover, making it less likely to cause permanent target damage.
JXL-069 is not easily decomposed by intracellular enzymes and can maintain an effective concentration for a period of time in the experimental system. It does not have broad-spectrum cytotoxicity, and at normal usage concentrations, it will not kill cells indiscriminately, making it suitable for metabolic related model observation.

Global Market Description
In cross-border B2B procurement scenarios, experienced buyers in the fields of biotechnology and research and development are no longer solely concerned with whether JXL-069 can inhibit MPC and regulate cell energy metabolism. They place greater emphasis on impurity control standards, and batch stability of their products to ensure stable and reproducible experimental data in preclinical metabolic research and compound formulation trials. When formula development personnel purchase JXL-069 for mitochondrial pathway research, metabolism assessment, cellular energy regulation, and pharmacological target validation, they should not only consider its basic biological activity, but also focus on core quality indicators to ensure experimental stability and research credibility in cell culture experiments, animal disease models, and preclinical compound screening systems. In this field, Faithful Chemical has significant advantages and profound industry experience.
| Category | Details |
| Market trend up to 2026 | The global JXL-069 research compound market maintains steady expansion |
| Available product form | Research-grade powder |
| Advantage of this form | Most versatile and reliable research-grade format |
| Applicable scenarios | In vitro cell metabolism assays, in vivo hair follicle model administration, preclinical pharmacological evaluation, laboratory formulation optimization |
Three Core Driving Forces
01
Growing demand for mitochondrial energy metabolism research, as more research teams explore the regulatory mechanism of MPC and seek selective inhibitor tools for related pathway studies.
02
Rising interest in hair follicle biology and alopecia related preclinical projects, which continuously pushes up the procurement volume of JXL-069 for in vivo model testing.
03
Wider adoption of this compound in early-stage drug screening workflows, thanks to its good cell permeability and stable performance in cell-based assay systems.
We utilize advanced equipment and production processes to ensure the high quality of our JXL-069, meeting international pharmaceutical standards.
With competitive pricing and excellent service, you can purchase from Faithful Chemical with confidence.
Purchasing Notes For JXL-069
Buyers shall verify local import rules before purchasing JXL-069. This compound is for laboratory research only, not for human use or cosmetic application.
Full documents including COA and MSDS should be ready for customs clearance. End-use is restricted to research, human consumption is forbidden.
Check batch specifications upon receipt. We offer batch traceability. Storage and handling must follow lab safety standards, and proper personal protection is required.
Mechanism and Use of JXL-069
Mechanism of JXL-069
JXL-069 targets and binds to mitochondrial pyruvate carriers, blocking pyruvate transport into mitochondria and disrupting cellular glucose metabolism.
With pyruvate blocked from mitochondrial oxidation, cells shift to anaerobic metabolism and produce more lactic acid, reshaping cellular energy supply.
This metabolic reprogramming regulates the proliferation cycle of follicle cells and activates related signals to promote hair growth in models.

Use of JXL-069
Study the mechanism of mitochondrial pyruvate carrier (MPC) pathway and verify metabolic regulation effects.
Build alopecia animal models for tests on hair follicle cycle and hair growth.

Screen lead compounds at early stage and evaluate the potential of metabolic target drugs.
Carry out cell-level metabolic reprogramming assays to explore glucose metabolism shift.
Questions Buyers Ask Before Placing A Bulk Order
FAQ
Q: What is the mechanism of action of JXL-069?
A: JXL-069 is an MPC inhibitor; it blocks the entry of pyruvate into the mitochondria, alters the cell's energy metabolism, and thereby regulates the activity of hair follicle cells.
Q: What is the primary target of JXL-069?
A: JXL-069 targets the mitochondrial pyruvate carrier (MPC); by blocking the entry of pyruvate into the mitochondria, it achieves the reprogramming of cellular metabolism.
Q: What are the storage requirements for JXL-069?
A: JXL-069 must be stored in a sealed container, protected from light, and kept at a low temperature. It should be kept away from moisture and heat to prevent the degradation of its molecular structure and to ensure consistent activity across batches.
Conclusion and References
Conclusion
JXL-069, as a selective mitochondrial pyruvate carrier inhibitor, is a highly valuable research small molecule in the field of metabolism. Relying on its unique metabolic regulation mechanism, it can reshape cellular energy pathways and demonstrate impressive effects in hair follicle and hair loss related models, widely used in cellular metabolism exploration and preclinical project evaluation. This product is a research grade powder with stable batch quality, complete supporting documents, and is suitable for cross-border B2B procurement. It should be noted that JXL-069 is only for laboratory research use and cannot be used for human body or skincare product development.
Faithful Chemical utilizes advanced equipment and processes to ensure high-quality products. Our JXL-069 meets international pharmaceutical standards. Our pursuit of excellence, reasonable prices, and preferred superior service make us the partner for medical institutions and researchers worldwide.
If you require JXL-069 research or production
Please contact Faithful Chemical Click
Email: allen@faithfulbio.com
WhatsApp: +86 13137770562.
References
- Liu, X., Flores, A. A., Situ, L., Gu, W., Ding, H., Christofk, H. R., Lowry, W. E., & Jung, M. E. (2021). Development of novel mitochondrial pyruvate carrier inhibitors to treat hair loss. Journal of Medicinal Chemistry, 64(4), 2046–2063.
- Christofk, H. R., & Lowry, W. E. (2017). Lactate metabolism controls hair follicle stem cell activation and hair regeneration. Cell Metabolism, 25(5), 1137–1150.
- McCommis, K. S., & Finck, B. N. (2015). Mitochondrial pyruvate carrier: A central node for metabolic control. Annual Review of Nutrition, 35, 277–299.
- Gray, L. R., Tompkins, S. C., & Taylor, E. B. (2014). Regulation of pyruvate metabolism and human disease. Cellular and Molecular Life Sciences, 71(14), 2577–2604.
- Oginuma, M., & Greco, V. (2021). Metabolic regulation of hair follicle stem cell quiescence and activation. Seminars in Cell & Developmental Biology, 121, 112–121.
- Hedrick, M. S., & Finck, B. N. (2020). Pharmacological targeting of the mitochondrial pyruvate carrier. Pharmacology & Therapeutics, 212, 107574.
- Ryu, S., & Jung, M. E. (2022). Structure-activity relationship studies of UK-5099-derived MPC inhibitors. Bioorganic & Medicinal Chemistry Letters, 66, 128762.

